Editorial
After iron, Zinc is the second most abundant trace metal in
the human body. Zinc has a main role in various cellular functions
such as maintenance of immune health. This property of zinc is of
great significance in the COVID-19 pandemic. Studies show that
Zinc exhibits antiviral activity through inhibition of SARS-CoV RNA
polymerase. It also regulates inflammatory response and modulates
antiviral and antibacterial immunity. [1,2]
Studies show that Zinc produces significant effect on viral
infections by variation in viral fusion, replication and translation
of viral protein. Trial show that Zinc supplementation in COVID
19 patients decreased airway neutrophil infiltration and
TNF-α release by impeding NF-kB-dependent transcription of
inflammatory genes. [1,2] According to recent research Zinc can be
used as adjunct therapy for viral life-threatening infections such as
COVID 19. Zinc repletion produces anti-viral effects, moderates the
cytokine storm, helps in early recovery, as it causes renewed nucleic
acid and protein synthesis. [3] Zinc is an essential nutrient that has
antiviral properties. Further research is essential to understand its
therapeutic potential against life-threatening viral infections.
References
- Pal A, Squitti R, Picozza M, Anil Pawar, Mauro Rongioletti, et al. (2020) Zinc and COVID-19: Basis of Current Clinical Trials. Biol Trace Elem Res, p. 1-11.
- Skalny AV, Rink L, Ajsuvakova OP, Michael Aschner, Viktor A Gritsenko, et al. (2020) Zinc and respiratory tract infections: Perspectives for COVID‑19 (Review). Int J Mol Med 46(1): 17-26.
- Butters D, Whitehouse M (2021) COVID-19 and nutriceutical therapies, especially using zinc to supplement antimicrobials. Inflammopharmacology 29(1):101-105.